Immunoprecise Antibodies is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jennifer Lynne Bath, with a market cap of $50.0M.
No upcoming earnings scheduled for Immunoprecise Antibodies
No earnings announcement scheduled
Past 3 earnings reports for Immunoprecise Antibodies
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q3 2026 | -$0.06Est: -$0.04 | -50.0% | $3.0MEst: $3.5M | -14.4% | — |
| Dec 15, 2025 | Q2 2026 | -$0.05Est: -$0.01 | -400.0% | $3.0MEst: $4.0M | -25.7% | — |
| Sep 15, 2025 | Q1 2026 | -$0.07Est: -$0.04 | -75.0% | $2.3MEst: $4.1M | -44.3% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.